[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples